ReviewFrontiers in immunology2019

Natural Killer Cells in Myeloid Malignancies: Immune Surveillance, NK Cell Dysfunction, and Pharmacological Opportunities to Bolster the Endogenous NK Cells.

Mattias Carlsten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.